Daewoong secures US patent allowance for anti-aging mRNA technology

Daewoong Pharmaceutical has received a patent allowance from the US Patent and Trademark Office for an ionizable lipid technology used in its eTurna messenger RNA delivery platform. The allowance indicates that the patent application has been approved, although Daewoong must complete additional procedures before the patent is formally registered and enforceable in the US. The patent covers ionizable lipids used to form lipid nanoparticles. The nanoparticles are used to encapsulate mRNA strands t

By The Korea Herald